Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 31, 2007, Pages 12879-12883

  Loeffler, Markus ^a   Le'Negrate, Gaelle ^a   Krajewska, Maryla ^a   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Cancer therapy; Immunotherapy; Tumor homing

Indexed keywords

CYTOKINE; LYMPHOTOXIN BETA RECEPTOR; PROTEIN LIGHT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG RECEPTOR BINDING; GENE INSERTION; GENETIC ENGINEERING; HUMAN; INFLAMMATORY CELL; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SOLID TUMOR; TUMOR REJECTION;

ANIMALS; CELL LINE, TUMOR; FEMALE; GENE THERAPY; HUMANS; MICE; NEOPLASMS; PROTEIN ENGINEERING; SALMONELLA TYPHIMURIUM; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

HERPESVIRIDAE; MURINAE; MUS; SALMONELLA; SALMONELLA TYPHIMURIUM;

EID: 34547865745     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0701959104     Document Type: Article

References (26)

1. Coley WB (1893) Clin Orthop 262:3-11.
2. Herr HW (1997) Br J Urol 80:762-765.
3. Jackson AM, Ivshina AV, Senko O, Kuznetsova A, Sundan A, O'Donnell MA, Clinton S, Alexandroff AB, Selby PJ, James K, Kuznetsov VA (1998) J Urol 159:1054-1063.
4. Clairmont C, Lee KC, Pike J, Ittensohn M, Low KB, Pawelek J, Bermudes D, Brecher SM, Margitich D, Turnier J, et al. (2000) J Infect Dis 181:1996-2002.
5. Rosenberg SA, Spiess PJ, Kleiner DE (2002) J Immunother 25:218-225.
6. Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, et al. (2002) J Clin Oncol 20:142-152.
7. Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, Gentschev I, Goebel W, Szalay AA (2004) Nat Biotechnol 22:313-320.
8. Thamm DH, Kurzman ID, King I, Li Z, Sznol M, Dubielzig RR, Vail DM, MacEwen EG (2005) Clin Cancer Res 11:4827-4834.
9. Carrier MJ, Chatfield SN, Dougan G, Nowicka UT, O'Callaghan D, Beesley JE, Milano S, Cillari E, Liew FY (1992) J Immunol 148:1176-1181.
10. Marwick C (2003) Br Med J 326:181.
11. Wang JM, Deng X, Gong W, Su S (1998) J Immunol Methods 220:1-17.
12. Schneider K, Potter KG, Ware CF (2004) Immunol Rev 202:49-66.
13. Morel Y, Truneh A, Sweet RW, Olive D, Costello RT (2001) J Immunol 167:2479-2486.
14. Kellermann SA, Hudak S, Oldham ER, Liu YJ, McEvoy LM (1999) J Immunol 162:3859-3864.
15. Nagira M, Imai T, Yoshida R, Takagi S, Iwasaki M, Baba M, Tabira Y, Akagi J, Nomiyama H, Yoshie O (1998) Eur J Immunol 28:1516-1523.
16. Kim CH, Pelus LM, Appelbaum E, Johanson K, Anzai N, Broxmeyer HE (1999) Cell Immunol 193:226-235.
17. Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G (1995) J Exp Med 182:155-162.
18. Strieter RM, Polverini PJ, Arenberg DA, Kunkel SL (1995) Shock 4:155-160.
19. Sgadari C, Angiolillo AL, Tosato G (1996) Blood 87:3877-3882.
20. Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S, Xu M, Penman S, Hoffman RM (2005) Proc Natl Acad Sci USA 102:755-760.
21. Fan Z, Yu P, Wang Y, Wang Y, Fu ML, Liu W, Sun Y, Fu YX (2006) Blood 107:1342-1351.
22. Wang YG, Kim KD, Wang J, Yu P, Fu YX (2005) J Immunol 175:6997-7002.
23. Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, Schietinger A, Philip M, Schreiber H, Fu YX (2004) Nat Immunol 5:141-149.
24. Colvin RA, Campanella GS, Sun J, Luster AD (2004) J Biol Chem 279:30219-30227.
25. Galen JE, Nair J, Wang JY, Wasserman SS, Tanner MK, Sztein MB, Levine MM (1999) Infect Immun 67:6424-6433.
26. Damiano JS, Newman RM, Reed JC (2004) J Immunol 173:6338-6345.